Tumor Infiltrating Lymphocytes (TIL) Clinical Trials
12 recruitingBiologic
Phase 28Phase 15Early Phase 14
Showing 1–12 of 12 trials
Recruiting
Early Phase 1
A Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital)
Gastrointestinal Tumor
Shanghai Juncell Therapeutics50 enrolled1 locationNCT04960072
Recruiting
Early Phase 1
A Study of GC101 TIL in Advanced Breast Cancer (10hospital)
Breast CancerAdvanced Breast CancerTreatment Side Effects+1 more
Shanghai Juncell Therapeutics50 enrolled1 locationNCT05142475
Recruiting
Early Phase 1
Study of GC101 TIL in Brain Glioma (Soochow2)
Glioma
Shanghai Juncell Therapeutics50 enrolled1 locationNCT04943913
Recruiting
Early Phase 1
A Study of GC101 TIL in Advanced Solid Tumors (TR)
Advanced Solid Tumors
Shanghai Juncell Therapeutics20 enrolled1 locationNCT04967833
Recruiting
Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
Biliary Tract CancerCholangiocarcinomaBiliary Tract Neoplasms
Udai Kammula59 enrolled1 locationNCT03801083
Recruiting
Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
Uveal NeoplasmsMelanoma, Uveal
Udai Kammula47 enrolled1 locationNCT03467516
Recruiting
Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
Gastric Cancer
Udai Kammula240 enrolled1 locationNCT03935893
Recruiting
Phase 1Phase 2
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer
Esophageal CancerStomach CancerStomach Cancer Recurrent+4 more
Essen Biotech75 enrolled1 locationNCT06532799
Recruiting
Phase 1Phase 2
TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer
Breast CancerBreast Cancer MetastaticBreast Carcinoma+1 more
Essen Biotech85 enrolled1 locationNCT06532812
Recruiting
Phase 1Phase 2
Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer
Essen Biotech85 enrolled1 locationNCT06530303
Recruiting
Phase 1Phase 2
TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
Brain MetastasesBrain TumorBrain Cancer+4 more
Essen Biotech85 enrolled1 locationNCT06640582
Recruiting
Phase 1Phase 2
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer
Lung CancerLung Cancer Metastatic
Essen Biotech85 enrolled1 locationNCT06538012